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Abstract The comprehensive metabolomic analyses using
eukaryotic and prokaryotic cells are an effective way to iden-
tify biomarkers or biochemical pathways which can then be
used to characterize disease states, differences between cell
lines or inducers of cellular stress responses. One of the most
commonly used extraction methods for comprehensive meta-
bolomics is the Bligh and Dyer method (BD) which separates
the metabolome into polar and nonpolar fractions. These
fractions are then typically analysed separately using hydro-
philic interaction liquid chromatography (HILIC) and
reversed-phase (RP) liquid chromatography (LC), respective-
ly. However, this method has low sample throughput and can
also be biased to either polar or nonpolar metabolites. Here,
we introduce a MeOH/EtOH/H2O extraction paired with
HILIC-time-of-flight (TOF)-mass spectrometry (MS) for
comprehensive and simultaneous detection of both polar and
nonpolar metabolites that is compatible for a wide array of
cellular species cultured in different growth media. This meth-
od has been shown to be capable of separating polar metabo-
lites by a HILIC mechanism and classes of lipids by an
adsorption-like mechanism. Furthermore, this method is scal-
able and offers a substantial increase in sample throughput
compared to BD with comparable extraction efficiency. This
method was able to cover 92.2 % of the detectable
metabolome of Gram-negative bacterium Sinorhizobium
meliloti, as compared to 91.6 % of the metabolome by a
combination of BD polar (59.4 %) and BD nonpolar
(53.9 %) fractions. This single-extraction HILIC approach
was successfully used to characterize the endometabolism of
Gram-negative and Gram-positive bacteria as well as mam-
malian macrophages.
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EtOH Ethanol
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HILIC Hydrophilic interaction liquid
chromatography
IS Internal standards
LC Liquid chromatography
MeOH Methanol
MS Mass spectrometry
OPLS-DA Orthogonal partial least-squares
discriminative analysis
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QC Quality control
RP Reversed-phase
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SM Sphingomyelin
Snthr Signal-to-noise threshold
TAG Triacylglycerol
TOF Time-of-flight
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Introduction
Cellular metabolomics is an important part of systems biology
as it reflects the phenotype of cells and monitors cellular
activities in a perturbed system [1, 2]. The metabolomic
profile of any organism represents a snapshot of its physio-
logical state and reflects the overall contributions from geno-
mic, transcriptomic, proteomic, and other environmental fac-
tors [3]. In vitro studies with cell cultures are convenient, fast,
cost-effective and more controllable compared to animal stud-
ies using sera, tissues or body fluids, yet are still able to
provide insight into biological functions [4]. Therefore, cellu-
lar metabolomics is capable of providing an understanding of
the global biochemical behaviour of a biological system.
Comprehensive cellular metabolomics facilitates
observation-driven, hypothesis-generating experiments by ex-
amining the entire detectable metabolome of a cellular system
in order to discover new biochemical phenomena [5]. Com-
prehensive metabolomics involves the analyses of diverse
chemical classes including but not limited to sugars, nucleo-
tides and organic acids with varying polarity, solubility and
volatility. The endogenous cellular concentration of many
metabolites can span over 12 orders of magnitude (from mM
to fM) [6, 7]. Expanding the diverse detectable metabolome
over a broad range of concentration, physical and chemical
properties is challenging yet crucial since multiple pathways
can often be influenced by a single external variable. In
particular, central carbon metabolism and lipid metabolism
are both involved in the inflammatory response of murine
macrophages undergoing lipopolysaccharide stimulation
[8–11]. The quality of the results often relies on the extent of
metabolome coverage in order to unveil the biochemical
changes entirely.
Liquid chromatography combined with mass spectrometry
equipped with an electrospray ionization source (LC-ESI-MS)
is the predominant analytical methodology used for compre-
hensive metabolomics [12–14]. The dynamic range of time-
of-flight (TOF)MS is often greater than 3 orders of magnitude
[15] and affords untargeted detection of relatively abundant
metabolites with little sample pretreatment. The detected me-
tabolite features, including ion source fragments, adducts and
isotopic ions, are defined by a unique combination of m/z and
retention time value. The relative abundances of the collective
list of metabolite features are used to evaluate and compare
different treatments [16]. Many comprehensive metabolomics
reports to date are focused on either the polar or lipid fractions
of the metabolome. The few studies that reflect true compre-
hensive metabolome have analysed the polar fraction using
hydrophilic interaction liquid chromatography (HILIC) and
the lipid nonpolar fraction using reversed-phase (RP) LC with
C18 or C8 columns [17–20]. The polar and lipid fractions are
conventionally extracted from a biological sample using the
Bligh and Dyer (BD) method [21]. There is also a single
extraction-dual separation LC-MS for the analysis of a single
extract containing both polar and nonpolar metabolites sepa-
rately on HILIC and RPLC [16]. Both methods are able to
ensure global coverage of the metabolome; however, these
methodologies are time consuming in sample preparation and
analysis.
Here, we present a reproducible, high-throughput, single-
extraction HILIC approach for comprehensive cellular
metabolomic analysis. This approach is able to simultaneous-
ly analyse a broad range of polar and nonpolar metabolites,
which is ideal for a large-scale hypothesis-generating study
with twofold faster data acquisition and analysis time when
compared to the conventional methods. The metabolome cov-
erage of the scalable extraction was compared to both the
polar and the nonpolar fractions of BDmethod. This approach
has been successfully applied to three different cell types: the
Gram-positive bacterium Streptococcus intermedius, the
Gram-negative bacterium Sinorhizobium meliloti and mam-
malian macrophages. The overall metabolome coverage ob-
served with this single-extraction HILIC approach is equiva-
lent to the BD method with separate analyses of polar and
nonpolar fractions.
Experimental
Chemicals
HPLC-grade methanol (MeOH), ethanol (EtOH), acetonitrile
(ACN), chloroform (CHCl3) and water (H2O) were purchased
from Caledon laboratories (Georgetown, ON, Canada). Am-
monium acetate and formic acid were purchased from Fisher
Scientific Company (Ottawa, ON, Canada). The 2.0-mm steel
chrome ball bearings were purchased from Bearing & Oil
Seals Specialists Inc. (Hamilton, ON, Canada). The isotopi-
cally labelled standards for recovery determination (RS) and
for peak intensity normalization (IS) were purchased from
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Cambridge Isotope Laboratories (Andover, MA, USA). Lipid
standards were purchased from Avanti® Polar Lipids, Inc.
(Alabaster, AL, USA), and other chemical standards for LC-
MS were purchased from Sigma Aldrich (St. Louis, MO,
USA) and Biolog Inc. (Hayward, CA, USA). The full list of
metabolite standards can be found in the Electronic Supple-
mentary Material Table S1.
Cell culture and collection
Detailed growth conditions for the Gram-negative bacterium,
S. meliloti, the Gram-positive bacterium, S. intermedius, and
murine macrophages are included in the Electronic Supple-
mentary Material Section 1. Detailed discussion regarding
quenching methods for cellular metabolism and detachment
protocol for adherent cells can be found in the Electronic
Supplementary Material Sections 2–5 and Fig. S1. The entire
harvesting and extraction process was performed on ice or in a
4 °C cold room.
Suspension bacterial cell culture
Cells were cultured in either 5-mL autoclaved test tubes or in
sterile 96-well plates (Corning® Costar®, NY, USA). The
suspension cell cultures were centrifuged at 9,500×g
(13,000 rpm) at 4 °C in a Beckman Coulter Allegra X-22R
centrifuge for 3 min, and the supernatants were carefully
aspirated with micropipette and discarded. The cell pellet
was resuspended in 1 mL of cold saline solution (0.85 %
NaCl) or phosphate-buffered saline (PBS). The mixture was
centrifuged at 9,500×g for 3 min, and the wash solvent was
aspirated and discarded. Extraction solvent of 100 μL (1:2:1
MeOH/CHCl3/H2O, 1:1 MeOH/EtOH or 2:2:1 MeOH/EtOH/
H2O) containing RSwas added to the washed cell pellet which
was then extracted immediately.
Adherent macrophage cell culture
For adherent macrophage cultures in 6-well tissue culture
plates (Falcon®, NY, USA), the growth mediumwas aspirated
carefully with a micropipette. The cells were quickly washed
with 1 mL of cold saline or PBS. After removing the wash
solvent via aspiration, 200 μL of extract solvent (1:1
MeOH/H2O for BD, 1:1 MeOH/EtOH or 2:2 :1
MeOH/EtOH/H2O) containing RS was added to each well.
Cells were detached from the culture plate using a cell lifter in
the presence of the extraction solvent, and the cell mixture was
transferred into a 1.5-mL microtube (Diamed, Mississauga,
ON, Canada). Only for the Bligh and Dyer extraction, 200 μL
volume of CHCl3 was also added to the microtube, and the
mixture was extracted immediately. The volume of the extrac-
tion solvent should be adjusted to the size of the well if other
types of microtiter plates were used.
Intracellular metabolite extraction
The extraction protocol was optimized using S. meliloti (2×
109 cells) and applied to S. intermedius (1×109 cells) as well
as murine macrophages (3×105 cells). RS were prepared such
that the final concentrations of L-methionine-d3, L-tryptophan-
d5 and L-lysine-
13C6-
15N2 were 27, 24 and 20 μM, respec-
tively, in the final reconstituted cell extracts. The final extracts
were blown down to dryness under a gentle stream of nitrogen
gas and reconstituted in 50 μL of 60 %v/v ACN/H2O contain-
ing L-phenylalanine-d8 (25 μM), Gly-Phe (16 μM), Phe-Phe
(6 μM) as well as cytidine-ribose13C5 (20 μM) as IS. To
minimize variability, sample extractions, addition of IS and
preparation of quality control (QC) samples were prepared in
the same day using the same batch of solvents. The final
endogenous cellular extracts were stored at −80 °C freezer
until HILIC-ESI-TOF-MS analyses.
Bligh and Dyer extraction
The extraction process was based on the method of Bligh and
Dyer [21] to achieve a biphasic separation by using 1:2:1
MeOH/CHCl3/H2O as the extraction solvent. The top
MeOH/H2O fraction contained polar metabolites, and the
bottom CHCl3 fraction contained nonpolar metabolites (i.e.
lipids). The denatured proteins and other macromolecules,
such as DNA and RNA, were precipitated and suspended at
the interface between polar and nonpolar fractions. The cell
mixture was vigorously mixed by vortex for 2 min in the
presence of two 2.0-mm ball bearings. After removal of the
bearings, the cell mixture was centrifuged at 9,500×g for
3 min. The polar fraction was collected, and the protein film
and the lipid fraction were re-extracted twice with 50 μL of
cold MeOH/H2O (1:1) with the same ball bearings. The
combined polar fraction was back-extracted twice with
50 μL of cold CHCl3, and the nonpolar CHCl3 fractions were
collected and combined with remaining CHCl3 fraction from
the previous polar extraction. In total, 150 μL of polar and
nonpolar fractions of bacterial extracts or 300 μL from adher-
ent cell cultures was collected.
MeOH/EtOH/H2O extraction
This extraction protocol was based on a plasma extraction
procedure adopted from Bruce et al. [22]. An extraction
solvent of 2:2:1 MeOH/EtOH/H2O or 1:1 MeOH/EtOH was
used to generate a single fraction which contained a mixture of
polar and nonpolar lipid metabolites. Proteins and other mac-
romolecules were precipitated. Prior to extraction, 10 μL of
RS was added to the cell mix. The cell mixture was mixed
rigorously by vortex for 2 min in the presence of two 2.0-mm
ball bearings. After removal of the bearings, the mixture was
centrifuged at 9,500×g for 3 min. The supernatant was
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collected, and the precipitated pellet (containing DNA, RNA
and proteins) was re-extracted twice with 50 μL of the cold
corresponding extraction solvent with bead beating. A total of
150 μL cell extracts was collected for suspended cell cultures,
or 300 μL was collected for adherent cell culture.
LC-MS analysis
The endogenous cellular extracts were analysed using an
Agilent Technologies 1200 RR Series II LC coupled to a
Bruker MicrOTOF II Mass Spectrometer. An injection of
2 μL was separated on a 50 mm×2.1 mm Kinetex 2.6 μm
HILIC column of a pore size of 100 Å (Phenomenex, CA,
USA). The mobile phases were HPLC-grade acetonitrile (A)
and 10mM ammonium acetate in HPLC-grade water adjusted
to pH 3 with formic acid (B) at a flow rate of 200 μL/min. The
column temperature was maintained at 40 °C, and the auto-
sampler storage tray was set at 4 °C. The mobile phase
gradient eluted isocratically with 95 % ACN for 0.5 min
followed by a gradient to 35 % ACN over 12 min. The
gradient was maintained at 35 % ACN for 0.5 min and
increased to 95 % ACN over 1 min. The gradient was then
followed by a 10-min re-equilibration prior to the next injec-
tion. The total time for the HILIC gradient was 24 min.
Positive ionizationmode (ESI+) and negative ionizationmode
(ESI−) were performed in separate runs. Details of the opti-
mization of the HILIC gradient method using 23 full factorial
design can be found in the Electronic Supplementary Material
Section 6 and Fig. S2.
The parameters chosen for ESI conditions were as follows:
4.0 bar of nebulizer pressure; −500 V of endplate offset;
−3,800 or 4,500 V of capillary voltage; 8.0 L/min of drying
gas flow rate; and 250 °C of dry gas temperature. The data
were acquired in profile mode from 50 to 1,000m/z at a scan
rate of 1.0 Hz (computed using a rolling average value of 2).
The mass accuracy was adjusted by internal calibration using
endogenous sodium formate clusters in both ESI+ and ESI−
with Bruker’s data analysis software.
Each of the extraction methods was repeated in sextupli-
cate, and all of the samples were analysed in random order. A
pooled QC sample was prepared by combining equal volumes
of all samples and divided into individual aliquots after thor-
ough mixing. The QC samples were stored in −80 °C freezer
along with the samples. A new QC sample and a day’s worth
of samples (about 20 samples) were thawed and ran each day
for a multiday experiment. The QC sample was injected five
times at the beginning of the analysis to condition the column
and also injected after every five samples. A solvent blank
(e.g. methanol) and a standard mixture containing all IS and
RS were also run after every ten samples. Post-column addi-
tion with Gly-Phe was performed on all different matrices for
different cell types in both ESI+ and ESI− modes for ion
suppression studies.
Data analysis
Raw data obtained from LC-ESI-mircOTOF-MS were con-
verted to the .mzXML file format using BrukerCompassxport
(http://www.bdal.com/navi/meta/home.html) after internal
calibration. The .mzXML files were then processed with
XCMS [23, 24] and CAMERA [25] in R Project (version 2.
12.2). A tabulated metabolite feature list with aligned
retention time and m/z values was exported in .csv format.
For XCMS, the centWave algorithm [24] was used for peak
picking with a resolution of 30 ppm and a signal-to-noise
threshold (snthr) set to 10. Features that appeared in less than
80 % of the samples which underwent the same extraction
method were removed (minfrac=0.8). The isotopic ions, in-
source fragments, and adducts were identified using
CAMERA.
Features with apparent retention factors kapp′ lower than 0.7
were removed because these were not retained and experi-
enced great ion suppression. The isotopic ions, ions associated
with IS, RS and sodium formate clusters were removed.
Metabolite features detected in the biological samples were
compared to those in the IS and RS solution in 60 %v/v ACN/
H2O, and the duplicated ions that were associated with the
background noise were removed. The peak areas of all me-
tabolite features were normalized using the peak area of IS
according to their retention time (see Electronic Supplemen-
tary Material Fig. S3). In-source fragments and adducts were
treated as separate metabolite features. Metabolite features
with peak areas under 2,000 were excluded. Features with
greater than 30 % variance in QC samples were removed.
Integration of non-Gaussian or coeluting peaks using XCMS
may generate inconsistent results. IS and RS with greater than
10 % variance and significantly differentiated metabolite fea-
tures with greater than 20 % variance were re-evaluated with
manual integration using Bruker DataAnalysis 4.0.
The processed data sets were used as an input for SIMCA-
P+ 11 software (Umetrics, Kinnelon, NJ). Pareto scaling was
applied prior to principal component analysis (PCA) and
orthogonal partial least-squares discriminative analysis
(OPLS-DA). OPLS-DA was used to differentiate metabolite
profiles between different extraction methods. The model
validation parameter Q2 (the fraction of variations of X and
Y matrices explained by the model; the X matrix was the
metabolite features, and the Y matrix was the treatment
groups) values above 0.4 were indicative of a robust model,
i.e. true differences between the comparing groups, and Q2
between 0.7 and 1.0 indicated that the model was highly
robust [26]. R2X (R2Y) indicated the fraction in which X (Y)
matrix was explained by the model. Two-tailed, unpaired
heteroscedastic Student’s t tests with p<0.05 were computed
in Microsoft Excel 2010 and used to identify metabolite
features that were significantly differentially expressed in each
extraction method. Metabolite features were identified by
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matching them/z and retention value to the available authentic
standards. Figures were created in Adobe Illustrator CS5.
Results and discussion
Comparison of extraction solvents
There have been extensive reviews that compare various
different extraction strategies for cellular metabolic analyses
[27–29]. Here, we have focused on comparing the extraction
efficiency of both polar and nonpolar metabolites with biphas-
ic solvent MeOH/H2O/CHCl3 (1:1:2) in the BD method [21]
to two other extraction solvents, MeOH/EtOH (1:1) and
MeOH/EtOH/H2O (2:2:1). BD extraction is commonly used
for comprehensive metabolomics to ensure full coverage of
both polar and nonpolar metabolites by running both polar
and nonpolar phases separately on HILIC and RPLC. Similar
to the BDmethod, MeOH/EtOH and MeOH/EtOH/H2O were
able to extract both polar and nonpolar metabolites, but with
all metabolites present in one single phase. Therefore, the
latter two extraction strategies, when compared to BD, were
able to minimize sample handling and also shorten the anal-
ysis time by a factor of two while still maintaining compre-
hensive coverage of both polar and nonpolar metabolites.
The scalable extraction method was tested on a 100-μL
S. meliloti (2×109) cell culture grown in M9 growth medium
in a 96-well microtiter plate. A bead-beating technique was
adopted instead of vortex mixing to ensure full cell disruption.
Sonication, though allowing complete cell disruption, was not
used in order to avoid overheating which may degrade ther-
mally labile metabolites. All three extraction solvents were
able to precipitate protein, DNA and RNA as well as provid-
ing good recovery for a wide range of both hydrophilic and
hydrophobic metabolites.
Based on the methionine-d3, the recoveries for the polar
fraction of BD (BD polar), MeOH/EtOH, and MeOH/EtOH/
H2O after three extraction procedures were 77±2 %, 59±5 %
and 79±2 %, respectively, for a sextuplicate experiment. A
much lower recovery was obtained for MeOH/EtOH when
compared to the two other extraction methods. MeOH/EtOH
failed to maintain a compact protein pellet during the extrac-
tion process; therefore, an extra centrifugation was required
for MeOH/EtOH extraction to remove particulates in the
sample extract. Moreover, based on the selected 24 endoge-
nous metabolites in S. meliloti, the extra centrifugation step in
MeOH/EtOH could also have caused lower extraction effi-
ciencies when compared to MeOH/EtOH/H2O solvent (see
Electronic Supplementary Material Fig. S4). Minimal sample
handling and short-time extraction procedures are critical for
large-scale metabolomic studies in order to achieve greater
reproducibility and sensitivity and to prevent metabolite mod-
ification and degradation with time [14, 30]. In terms of ease
of performance, the MeOH/EtOH/H2O extraction procedure
outperformed MeOH/EtOH and the two-staged extraction
procedure of BD for comprehensive polar and nonpolar me-
tabolite analyses. Hence, the MeOH/EtOH/H2O was further
optimized to achieve better extraction efficiencies and
robustness.
The optimal numbers of extraction processes required in
order to reach a minimal of 95 % extraction efficiency of the
selected endogenous metabolites was determined by
extracting a 100-μL S. meliloti cell culture using
MeOH/EtOH/H2O seven times. Each extraction was per-
formed in sextuplicate. The percentages of recoveries of 20
endogenous metabolites from S. meliloti at each extraction
step were calculated by dividing the relative abundance of
each individual metabolite at each step with its sum in all
seven extractions (Fig. 1). Most metabolites showed greater
than 80 % recovery upon the first extraction. Among them, N-
acetyl-aspartic acid, adenosine monophosphate (AMP),
methylhistidine and acetylcarnitine were entirely (100 %) re-
covered in the first extraction. The second extraction was able
to recover the remaining 10–15 % for most of the metabolites.
Metabolites such as γ-aminobutyric acid, adenine, adenosine
and proline were persistent and were still detected after the
seventh extraction. Therefore, a minimum of two
MeOH/EtOH/H2O extraction steps were required to ensure
at least 95 % extraction efficiency for the major endogenous
metabolites. We recommend extracting cells three times to
ensure great extraction efficiency and reproducibility.
The dissolution solvent has a significant impact on peak
shapes in HILIC chromatography [31]. The samples were
concentrated in order to improve the detection limit. Sample
volume was reduced to 50 μL by drying with a gentle stream
of nitrogen, and the remaining solvent was primarily com-
posed of water as it was the least volatile solvent in the
MeOH/EtOH/H2O extracts. Water is not an appropriate dis-
solution solvent for HILIC gradients with a high percentage of
ACN because it causes peak broadening and, consequently,
reduces sensitivity [31]. Therefore, samples were dried
completely to remove all residual water and reconstituted in
a solvent mix low in water to also minimize irreproducibility
due to inconsistent sample volumes. We have adopted the use
of 60 %v/v ACN/H2O to ensure adequate peak shape and
sensitivity while still allowing full dissolution of the highly
polar metabolites.
HILIC/MS for simultaneous detection of both polar and lipid
metabolites
HILIC is typically used to separate polar compounds via
hydrophilic partitioning mechanism. In 2010, HILIC was
reported to be able to retain lipids, especially phospholipids,
according to the polarity of the lipid heads [32, 33]. Therefore,
since HILIC can simultaneously separate polar and lipid
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metabolites, it was selected as the chromatographic method
for high-throughput comprehensive metabolomic analyses.
RPLC is often used to retain and separate nonpolar analytes
[34]. Separation of polar compounds can also be achieved
with RPLCwith an ion-pairing agent in the mobile phase [35];
however, the ion-pairing reagents often lead to contamination
in the MS instrument [36] and, therefore, were not preferred.
Unlike RPLC, small changes in pH and buffer ionic
strength can often cause large retention deviations in HILIC
[37]. To improve reproducibility and minimize retention de-
viation for better retention time alignment using XCMS, con-
sistent preparation of the mobile phase was critical. For large-
scale comprehensive metabolomic analyses, all samples
should be run using the same batch of mobile phases. The IS
and RS spiked in each biological samples should also be used
to correct retention time drift of metabolites when assigning
metabolite identification based on the retention time of au-
thentic standards. HILIC separations are less tolerant of fast
gradients and require a longer equilibrium time compared to
RPLC. Though the starting gradient at 98 % ACN was able to
retain a greater amount of metabolite features, it required
much longer equilibration time (more than 10 min) than
starting at 95 % ACN (8–10 min). Running blanks and pooled
samples at the beginning of the HILIC sequence is critical in
order to condition the column to minimize variation in peak
shape, retention time and ionization response.
HILIC is able to retain phospholipids or other polar lipids
via an adsorption mechanism [32]. Silica HILIC was chosen
specifically for optimized phospholipid separation at low buffer
strength instead of other commonly used zwitterionic or diol
HILIC [32, 38]. The low buffer ionic strength of 10 mM
ammonium acetate in mobile phase B allowed secondary inter-
actions between the HILIC stationary phase and the polar lipid
head groups via hydrogen bonding and electrostatic interaction.
Therefore, our optimized HILIC gradient was able to separate
phospholipids by classes based on their polar head group.
Though each lipid class eluted within a very narrow time
window (often within 1min), there were still separations within
each lipid class based on hydrophobicity (carbon chain length)
and unsaturation (number of C=C bonds) (Fig. 2). The lipid
class separation achieved with HILIC in combination with the
sub-5-ppmmass accuracy attained with internal calibration was
able to accurately identify lipid metabolites without running
copious authentic standards. Isomers between phosphatidyl-
choline (PC) and phosphatidylethanolamine (PE) could be
accurately identified because PCs and PEs were chromato-
graphically separated. Figure 3 summarizes 2,125 metabolite
features (after data reduction) detected in the intracellular ex-
tracts ofmurinemacrophage. Different classes of phospholipids
including phosphatidylglycerol, PCs, PEs and lyso-PCs were
detected along with small polar metabolites such as nucleo-
sides, amino acids and organic acids. The ability of HILIC to
separate both polar and lipid compounds combined with our
extraction methodology allowed simultaneous analyses of both
polar and lipid metabolites for enhanced sample throughput.
Mass accuracy can be significantly improved by the usage
of sodium formate as an internal calibrant which was formed
by the endogenous sodium ions in the cell and the formic acid
in mobile phase B. The presence of sodium formate adducts
with retention times at 7.2 min was used for internal mass
calibration in both ESI+ and ESI− modes which dramatically
improved mass accuracies for all three cell types grown in
different biological media (see Electronic Supplementary Ma-
terial Table S2). The confidence of metabolite identification
was improved significantly with the sub-5-ppmmass accuracy
attained after internal calibration with sodium formate.
The endogenous sodium formate also caused minor ion
suppression regardless of the biological matrix of interest (see
Fig. 1 The extraction efficiencies of endogenous metabolites in 2×109
S. meliloti cells. a The extraction efficiencies in the first extraction and b
the extraction efficiencies were further explored with the second to the
seventh extractions (only second, third and seventh extractions are
shown). The extraction efficiencies at each extraction step were calculated
by first normalizing the peak area of each metabolite with internal
standards and then dividing the relative abundance of each individual
metabolite at each step with its sum in all seven extractions. The error
bars corresponded to two standard deviations. AMP, adenosine
monophosphate
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Electronic Supplementary Material Fig. S5). The IS,
phenylalanine-d8, eluted in the ion suppression region and
was used to normalize peak areas of metabolite features elut-
ing in the region to correct for varying degrees of ion suppres-
sion in different samples.
The current method was applied to the comprehensive
metabolomic analyses of S. meliloti, S. intermedius and mu-
rine macrophages. Over a continuous 7-day injection series of
S. meliloti extracts, the retention time deviation was less than
7 s in a 24-min LC runwith approximately 260,000metabolite
features in 137 samples (1,900 features per sample over 137
samples in ESI+) analysed by XCMS using the centWave
method (see Electronic Supplementary Material Fig. S6).
The peak area deviations of IS were all below 10 %. The
QC and sample data were analysed with PCAwith QC sam-
ples clustered tightly in the centre of the score plot, indicating
that instrumental variability was minimal. The optimized
HILIC-TOF-MS method was highly robust and reproducible.
Metabolome coverage from the MeOH/EtOH/H2O extraction
compared to the two fractions of the Bligh and Dyer method
Untargeted comprehensive large-scale metabolomics de-
mands that the experimental method have high sample
throughput, high robustness to sustain long LC sequence
and excellent metabolome coverage. We propose using a
MeOH/EtOH/H2O extraction in combination with HILIC-
TOF-MS to encompass both polar and nonpolar metabolites
in a single analysis. Compared to the conventionally used BD
method in which polar and nonpolar fractions are analysed
separately, the proposed method doubles the throughput and
minimizes the sample handling time with comparable repro-
ducibility. The metabolome coverage of the proposed method
was compared to both of the polar and nonpolar fractions
obtained using BD methods.
Traditionally, the BD polar fraction was run using HILIC,
and the BD nonpolar fraction was run using RPLC [18, 19,
Fig. 2 a Base peak
chromatogram of the HILIC
separation on ten lipid classes
including PGs, lyso-PG,
phosphatidic acids (PAs), PSs,
triacylglycerols (TAG), PEs,
ceramides (CEs), PCs,
sphingomyelins (SMs) and lyso-
PCs. b Base peak chromatogram
of [M+H]+ ions of PEs
Fig. 3 The 2,125 endogenous
metabolite features detected in 3×
105 murine macrophage extracts
after data reduction. The radius of
the data markers (filled circle)
reflected the relative abundances
of the metabolite features over a
dynamic range of 5×104. Small
metabolites (90–400m/z) in
orange, PGs in green, PEs in red,
PCs in purple and lyso-PCs in
bluewere highlighted. TheHILIC
gradient was labelled with a black
line with reference to percentage
acetonitrile
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39]. However, in order to directly compare the extraction
efficiency of nonpolar metabolites, the BD nonpolar fraction
was also run using the same optimized HILIC method as used
for the MeOH/EtOH/H2O extracted samples and BD polar
extracts. Evaluating all three extract samples using the same
LCmethod has also allowed us to comparemetabolite features
that were found in common between all three extracts. How-
ever, more features were expected when analysing the BD
nonpolar fraction with RPLC in comparison to HILIC. Triac-
ylglycerols, diacylglycerols and fatty acids, which were com-
monly analysed with RPLC, cannot be retained using HILIC,
and were eluting in the unquantifiable dead volume with
retention time below kapp′ 0.7. Gram-negative bacteria
S. meliloti was used to compare the metabolome coverage
and extraction efficiency of MeOH/EtOH/H2O to BD polar
and BD nonpolar extracts.
The XCMS centWave algorithm in combination with
CAMERA has deconvoluted a total of 3,378 metabolite fea-
tures. All those features were present in at least one of the
MeOH/EtOH/H2O, BD polar and BD nonpolar extracts.
There were more features detected in the ESI- mode (1,900)
compared to ESI+ mode (1,478). Metabolite features from
solvent contamination, instrumentation noise and spiked IS
and RS that were shared in the extracted samples and the
standard mixture containing IS and RS were removed (un-
paired heteroscedastic t test, p>0.05 between all extracts and
standard mixtures). Any features that were eluted in the dead
volume with kapp′<0.7 were removed because they were
Fig. 4 The metabolome coverage of S. meliloti of the 1,059 endogenous
metabolite features found in at least one set of BD polar, BD nonpolar or
MeOH/EtOH/H2O extracted samples. Extracts were performed in sextu-
plicate and analysed independently by HILIC-TOF-MS in both ESI+ and
ESI− modes. The ionization responses of the metabolite features were
normalized using internal standards. a OPLS-DA score plot comparing
the endogenousmetabolome coverage of S. meliloti extracts attained from
three different extraction methods with R2X(cum)=0.926, R2Y(cum)=
0.986 and Q2(cum)=0.936. b The quantity of metabolite features that
were uniquely identified and shared between BD polar, BD nonpolar and
MeOH/EtOH/H2O extracted samples was listed in the Venn diagramwith
their estimated percentage share of the total detectable metabolome. c The
normalized ionization responses of identified metabolites with varying
polarities. The ionization responses from MeOH/EtOH/H2O extracts
were set to one as references. Polar metabolites were mostly extracted
in BD polar, and lipids were seen exclusively in BD nonpolar; however,
all metabolites were detected in MeOH/EtOH/H2O. Error bars
corresponded to two standard deviations. UDP, uridine diphosphate;
GlcNac, N-acetylglucosamine
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unquantifiable due to severe ion suppression. The isotopic
ions annotated by CAMERA were also removed along with
ions associated with sodium formate clusters. After data re-
duction, a final list of 1,059 metabolite features was attained.
The data reduction process was important to reduce the quan-
tity of redundant data and false positives during statistical
analyses.
Multivariate analysis using OPLS-DA revealed that all
three types of extracts had unique metabolome profiles
(Fig. 4a). The model was robust with Q2(cum)=0.936 and
describes nearly all variables with R2X(cum)=0.926 and
R2Y(cum)=0.986. All extracts from the MeOH/EtOH/H2O
extraction were clustered in between the BD polar and BD
nonpolar extracts, indicating shared metabolome profiles be-
tween MeOH/EtOH/H2O extracts and BD polar extracts as
well as nonpolar extracts. Since MeOH/EtOH/H2O extracts
were not centered in the OPLS-DA score plot, these extracts
contained some unique metabolite features that were absent in
the BD polar and BD nonpolar extracts.
Among the 1,059 detectable endogenous metabolite fea-
tures of S. meliloti, 59.4, 53.9 and 92.2 % were detected in BD
polar, BD nonpolar and MeOH/EtOH/H2O extracts, respec-
tively (Fig. 4b). Of the 7.8 % of the detectablemetabolome not
covered by the MeOH/EtOH/H2O method, 2.9 % were only
detected in BD polar, 4.5 % were only detected in BD non-
polar and 0.3 % were detected in both BD polar and nonpolar
fractions. There were 34.7 % of the features shared between
MeOH/EtOH/H2O and BD polar that were undetected in BD
nonpolar; among them, polar metabolites such as amino acids,
organic acids, sugar phosphates, nucleotides and nucleosides
Table 1 The shared 228 metabolite features in BD polar, BD nonpolar
and MeOH/EtOH/H2O extracts were compared between different extrac-
tion methods using unpaired heteroscedastic Student’s t test with p<0.05.
Among the shared features, 15.8 % showed greater extraction efficiency
(↑), 14.6% showed lower extraction efficiency (↓) and 59.6 % showed no
difference (≈) between MeOH/EtOH/H2O and BD fractions
Features detected Percentage features of
228 shared
Extraction efficiency of MeOH/EtOH/H2O
compared to BD
↑ 36 15.8 MeOH/EtOH/H2O>BD polar, BD nonpolar
↓ 5 2.2 BD polar>MeOH/EtOH/H2O>BD nonpolar
6 2.6 BD polar<MeOH/EtOH/H2O<BD nonpolar
2 0.9 MeOH/EtOH/H2O<BD polar, BD nonpolar
7 3.1 MeOH/EtOH/H2O=BD nonpolar<BD polar
36 15.8 MeOH/EtOH/H2O=BD polar<BD nonpolar
≈ 29 12.7 MeOH/EtOH/H2O=BD polar=BD nonpolar
39 17.1 MeOH/EtOH/H2O=BD nonpolar>BD polar
68 29.8 MeOH/EtOH/H2O=BD polar>BD nonpolar
“>”, greater extraction efficiency; “<”, less extraction efficiency; “=”, equal extraction efficiency. Metabolite features seen with greater ionization
responses in either BD polar and BD nonpolar fractions in comparison to those from MeOH/EtOH/H2O extracts were considered to have lower
extraction efficiencies in MeOH/EtOH/H2O and vice versa
Fig. 5 Among 228 shared metabolite features in BD polar, BD nonpolar
and MeOH/EtOH/H2O extracts, a 14.6 % features had lower extraction
efficiencies in MeOH/EtOH/H2O extracts than at least one of the BD
extracts, and b 15.8 % features had increased extraction efficiencies in
MeOH/EtOH/H2O extracts than all BD extracts. Each error bar
corresponds to two standard deviations calculated from six independent
extractions. The ionization responses were normalized to the IS and also
the total summed ionization response for both BD polar and BD nonpolar.
Each metabolite feature is represented by the ESI mode used for its
detection (in brackets), its m/z value and retention time
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were detected. There were 27.6 % of the features shared
between MeOH/EtOH/H2O and BD nonpolar that were not
detected in BD polar; lipids such as phosphatidylglycerols
(PGs), PEs, PCs and phosphatidylserines (PS) were among
those that were identified. There were 8.4 % of the metabolite
features that could only be detected in MeOH/EtOH/H2O
extracts, and they ranged in polarity and m/z values. A few
of the identified metabolites and their relative responses are
shown in Fig. 4c, and the ionization responses of all metabo-
lites in MeOH/EtOH/H2O were normalized to one as a refer-
ence. The MeOH/EtOH/H2O method had equivalent recover-
ies for vast majority of those endogenous polar and lipid
metabolites as compared to the separately analysed BD polar
or BD nonpolar extracts.
There were also 21.5 % of the features shared between
MeOH/EtOH/H2O, BD polar and BD nonpolar extracts.
Among those shared features, 59.6 % of the shared metabolite
features were equally extracted using MeOH/EtOH/H2O in
comparison to the most pronounced BD fractions based on
unpaired heteroscedastic Student’s t test of p<0.05 (Table 1).
In Fig. 5, the ionization responses of some selected shared
metabolite features were normalized against IS and the sum of
ionization response of BD polar and BD nonpolar which was
normalized to 1. The normalization was done under the as-
sumption that BD polar and BD nonpolar in combination have
a net 100 % recovery of all metabolites. MeOH/EtOH/H2O
had lower extraction efficiency in 14.6 % of the shared fea-
tures than at least one of the BD fractions (Fig. 5a). However,
15.8 % of the shared features had a greater recovery in
MeOH/EtOH/H2O than both of the BD fractions (Fig. 5b).
Many of those metabolite features were partially recovered in
both BD polar and BD nonpolar, but were more efficiently
recovered using MeOH/EtOH/H2O. If a conventional com-
prehensive metabolomic method was used with each of the
BD polar and nonpolar fractions run on either HILIC or RP,
then features that were partially extracted and present in both
fractions would be considered as different metabolites and
would be quantified separately and result in bias during mul-
tivariate analyses. Moreover, recovering these metabolites in
full using MeOH/EtOH/H2O results in higher injected con-
centrations and facilitates their detection. Therefore, the 8.4 %
of the metabolite features detected exclusively in the
MeOH/EtOH/H2O method would likely be low abundant
metabolites in the cells which were under a detection limit
when partially recovered in either of the BD fractions, but
detectable when more efficiently recovered in the
MeOH/EtOH/H2O extraction.
Based on all these results, MeOH/EtOH/H2O in combina-
tion with HILIC-TOF-MS provides a very robust, high-
throughput and comprehensive approach for cellular
metabolomic analyses. The metabolomic coverage of
MeOH/EtOH/H2O was comparable to the combined coverage
of BD polar and BD nonpolar yet was twice as efficient in
terms of data acquisition speed. The method was unbiased
towards neither of the polar or nonpolar metabolites.
Conclusion
The complex biological matrices and different culturing tech-
niques required for the growth of many cellular organisms
present a great challenge for comprehensive analyses. Large-
scale comprehensive metabolomic analyses involving hun-
dreds of samples often lead to time-consuming, labour-
intensive sample preparation, extraction and data acquisition.
The proposed comprehensive metabolomic protocol using
MeOH/EtOH/H2O extraction paired with HILIC-TOF-MS
analysis was able to expand metabolome coverage to both
polar and lipid metabolites with high reproducibility and
robustness with twofold faster data acquisition throughput
than the conventional Bligh and Dyer method coupled to RP
and HILIC-MS. This scalable extraction method was applica-
ble to Gram-positive and Gram-negative bacteria with rigid
cell walls as well as mammalian cells; it was applicable to both
suspension and adherent cell cultures that were grown in
either rich or minimal media and had minimal ion suppression
despite the complex biological matrix. This comprehensive
metabolomic method was developed as a qualitative initial
screening tool for finding biomarker or pathway differences
between treatments for a hypothesis-generating study. How-
ever, extension to quantitative targeted metabolomic analyses
should be followed for high-impact study.
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